Factors to Consider When Selecting a CDMO for Complex Injectables Development and ManufactureMay 3, 2021 12:00:00 AM
Ascendia Pharmaceuticals Secures Growth Equity Investment from Signet Healthcare PartnersApr 8, 2021 12:00:00 AM
Ascendia Overcomes Multiple Challenges to Successfully Formulate Compound for Pharma CompanyMar 25, 2021 12:00:00 AM
How Proper CDMO Partner Helps Overcome Challenges Associated with Drug Delivery of Poorly Water-soluble DrugsMar 8, 2021 12:00:00 AM
Ascendia Uses Experience, Advanced Proprietary Nano-technology to Develop CNS Formulation for Liquid-filled Capsule DeliveryFeb 1, 2021 12:00:00 AM